This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
06/29/15 - 3:59:55 PM ET (BATS BZX Real-time Price)
Div Yield: --
PODD Day's Range
PODD 52 Week Range
PODD Business Summary
Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States.View PODD key stats
Insulet Corp - PODD - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Insulet Corp as a
Sell with a ratings score of D+.
Report Snippet: We rate INSULET CORP (PODD) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally high debt management risk and generally disappointing historical performance in the stock itself.